Researchers from Jerusalem’s Hebrew University and Edinburgh  University, Scotland, uncovered how critical proteins, called transcription factors (TFs), define cellular identity. It raises the possibility of converting skin cells into heart cells, or insulin-producing cells to cure diabetes. https://timesofindia.indiatimes.com/science/breakthrough-for-bioengineering-as-study-deciphers-how-cells-define-their-identity/articleshow/116510751.cms https://phys.org/news/2024-12-reveals-transcription-factors-dna-architecture.html

Israel’s United Hatzalah first responder organization has implemented an Artificial Intelligence system developed by the IDF 8200 intelligence unit. It analyzes 18 years of historical emergency data and in trials has achieved a 85% accuracy rate in predicting locations and … Continue reading →

A consortium led by Prof. Hossam Haick of Israel’s Technion Institute has secured an eight million Euros grant from the European Union, for early diagnosis and monitoring of schizophrenia. The VOLABIOS project will analyze biomarkers derived from various sources in … Continue reading →

The UK Government’s G-Cloud 14 framework now includes the clinical decision-support software platform from Israel’s Seegnal eHealth (see here previously). UK NHS trusts, hospitals, and clinics can now easily procure Seegnal’s “Virtual Digital Pharmacist”. https://www.globenewswire.com/news-release/2024/12/02/2989889/0/en/Seegnal-E-Health-s-Virtual-Digital-Pharmacist-Approved-for-UK-Government-s-G-Cloud-14-Framework.html https://www.youtube.com/watch?v=UDkjr4c5yeg

PixCell Medical (see here previously) has achieved EU certification for its HemoScreen Complete Blood Count (CBC) analyzer. It is the first such device to pass the new, strict, European In Vitro Diagnostic Medical Devices Regulation (IVDR). It already is US-approved. … Continue reading →

A study led by Hebrew University of Jerusalem’s  Dr. Ido Goldstein has discovered that repeated fasting (e.g. on alternate days) triggers a cellular memory mechanism in the liver, improving its response to future fasting events, offering new insights into metabolic … Continue reading →

Researchers from the Hebrew University of Jerusalem, Israel’s Weizmann Institute and the University of Tokyo have created the peptide D’20 that  targets and inhibits an enzyme called Matrix Metallopeptidase 7 (MMP7). MMP7 helps cancer cells invade surrounding tissues. https://tps.co.il/articles/israeli-japanese-cancer-research-offers-new-to-hope-for-fighting-pancreatic-cancer/